コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 % CI, 1.84-4.16; both p < 0.001) compared to crystalloid.
2 6) were initially resuscitated with 10 mL/kg crystalloid.
3 ge vacuoles, they form a membrane-containing crystalloid.
4 , pigs were resuscitated with shed blood and crystalloid.
5 ong trauma patients is unknown compared with crystalloid.
6 s not more effective than treating with only crystalloids.
7 received synthetic colloids compared to only crystalloids.
8 eved equally fast with synthetic colloids or crystalloids.
9 branes adjacent to granular material and DNA crystalloids.
10 health record to compare saline to balanced crystalloids.
11 tion of intravenous fluids that was balanced crystalloids.
12 nal hemodynamics when compared with balanced crystalloids.
14 age, gender, comorbidities, blood products, crystalloid/12 hrs, presence of any head injury, injury
16 nosis (1C); initial fluid resuscitation with crystalloid (1B) and consideration of the addition of al
20 ndomized controlled trial comparing balanced crystalloid against 5% HAS as sole early resuscitation f
22 n addition to crystalloids, as compared with crystalloids alone, did not improve the rate of survival
24 of 1162 patients (99.1%) receiving buffered crystalloid and 1110 of 1116 patients (99.5%) receiving
25 and retrograde cardioplegia are superior to crystalloid and antegrade cardioplegia alone for postope
26 logical effects of ONOO(-) may exist between crystalloid and blood cardioplegia (BCP) environments.
29 id resuscitation with commercially available crystalloid and colloid solutions only provides transien
30 erformed to a target hemoglobin of 8.0 g/dL; crystalloid and colloid were used for volume replacement
33 gulated with citrate-phosphate-dextrose) and crystalloid and observed for the next 6 or 24 hours.
36 thy through permissive hypotension, limiting crystalloids and delivering higher ratios of plasma and
37 e family Brassicaceae, the PSVs lack visible crystalloids and have many small globoids dispersed thro
38 e examined the association between choice of crystalloids and in-hospital mortality during the resusc
40 lution may maintain hemodynamics better than crystalloids and reduce the decrease in platelet count a
43 lline lattice of membranes and proteins, the crystalloid, and one or a few large phytate crystals, th
44 rising estimated blood loss, total volume of crystalloid, and other colloid/hypertonic solutions admi
45 Saline, glucose-containing high chloride crystalloids, and balanced crystalloids represented 43%,
46 Hyponatremia was apparent in the isotonic crystalloid- and colloid-treated animals, but not in tho
47 decades after they were first described, the crystalloids are back in the spotlight, with recent disc
52 compared with 22 participants (14.8%) in the crystalloid arm (adjusted odds ratio, 1.50; 95% CIs, 0.8
55 es, anesthetic management, fluid management (crystalloids as well as hemoglobin-based oxygen-carrying
56 hock, fluid resuscitation with MES (balanced crystalloid) as compared with 0.9% saline resulted in a
57 e sepsis, albumin replacement in addition to crystalloids, as compared with crystalloids alone, did n
58 8 hr) comprised retransfusion of shed blood, crystalloids (balanced electrolyte solution), and norepi
60 to 90 minutes postorder; and 4) 30 mL/kg IV crystalloid bolus initiated less than or equal to 30 min
61 ) identify predictors of reaching a 30 mL/kg crystalloid bolus within 3 hours of sepsis onset (30by3)
63 at baseline and received similar volumes of crystalloid by 30 days (median [interquartile range]: 1,
65 ossover trial comparing saline with balanced crystalloids can produce well-balanced study groups and
67 in microbubbles within the myocardium during crystalloid cardioplegia (CP) infusion and ischemia-repe
68 earts were arrested for 60 minutes with cold crystalloid cardioplegia (iC-CCP; n=8) or with cold bloo
69 sted for 60 minutes with warm (37 degrees C) crystalloid cardioplegia (iW-CCP) (n=8) or with warm blo
70 followed by 60 minutes of intermittent cold crystalloid cardioplegia (Plegisol) and 2 hours of reper
71 he hypothesis that ONOO(-) is cardiotoxic in crystalloid cardioplegia but cardioprotective in BCP in
72 arts to 8 hours of hypothermic ischemia with crystalloid cardioplegia containing adenosine 0, 0.01, 0
74 investigated whether intermittent blood and crystalloid cardioplegia differentially affect myocardia
75 Extent of myocardial protection with cold-crystalloid cardioplegia in pediatric open heart surgery
78 sis) undergoing open heart surgery with cold-crystalloid cardioplegia were included in the study.
79 y donor hearts preserved by single dose cold crystalloid cardioplegia with greater than 8 hours of co
81 wed by 60 minutes of CPB, with 45 minutes of crystalloid cardioplegia, then 90 minutes of post-CPB re
82 to enhance myocardial protection afforded by crystalloid cardioplegia, volatile anesthesia and hypoth
86 dioplegic arrest and rewarming, incubated in crystalloid cardioplegic solution (24 mEq/L K+, 4 degree
87 the partial dilution of blood in 4:1 (blood:crystalloid) cardioplegic solutions may nullify these ad
88 balance, accounting for patient morphometry, crystalloid, colloid, blood products, urine, blood loss,
90 rhage should occur in successive steps using crystalloids, colloids, and red blood cells (RBCs) in th
92 tional coagulopathy after resuscitation with crystalloids/colloids clinically often appears as diffus
93 fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk
96 mental therapy for sepsis, but the effect of crystalloid composition on patient outcomes remains unkn
101 nts with hypovolemia, the use of colloids vs crystalloids did not result in a significant difference
102 Consistent with other proteins that induce crystalloid ER, viperin self-associates, and it does so
106 All patients admitted to the ICU requiring crystalloid fluid therapy were eligible for inclusion.
110 al ligation and puncture model incorporating crystalloid fluids and antibiotics, exhibiting improved
111 vity as the result of dilution followed with crystalloid fluids and artificial colloids (dextran and
116 regarding saline as the primary intravenous crystalloid for critically ill adults and highlights fun
117 Database, the use of a calcium-free balanced crystalloid for replacement of fluid losses on the day o
119 ked study fluid, either saline or a buffered crystalloid, for alternating 7-week treatment blocks.
122 ndomized to forced diuresis with intravenous crystalloid, furosemide, mannitol (if pulmonary capillar
124 made up a larger proportion of the isotonic crystalloid given in the saline group than in the balanc
125 thetized pig can be reversed or prevented by crystalloids given in a volume equivalent to Advanced Tr
128 luid was needed over the first 4 days in the crystalloid group (fluid ratios 1.4:1 [crystalloids to h
129 , 87 of 1152 patients (7.6%) in the buffered crystalloid group and 95 of 1110 patients (8.6%) in the
130 albumin group and 288 of 900 (32.0%) in the crystalloid group had died (relative risk in the albumin
131 albumin group and 389 of 893 (43.6%) in the crystalloid group had died (relative risk, 0.94; 95% CI,
134 albumin group, as compared with those in the crystalloid group, had a higher mean arterial pressure (
138 ) in colloids group vs 390 deaths (27.0%) in crystalloids group (relative risk [RR], 0.96 [95% CI, 0.
139 ) in colloids group vs 493 deaths (34.2%) in crystalloids group (RR, 0.92 [95% CI, 0.86 to 0.99]; P =
140 (11.0%) in colloids group vs 181 (12.5%) in crystalloids group (RR, 0.93 [95% CI, 0.83 to 1.03]; P =
141 cal ventilation in the colloids group vs the crystalloids group by 7 days (mean: 2.1 vs 1.8 days, res
142 otal of 217 patients (26.3%) in the balanced crystalloids group experienced 30-day in-hospital morali
144 wed higher mortality with starches than with crystalloids (high confidence) and lower mortality with
145 ocol groups: euvolemic (3 mLkg/hour isotonic crystalloid), hypervolemic (15 mL/kg/hour isotonic cryst
146 Isotonic saline is the most commonly used crystalloid in the ICU, but recent evidence suggests tha
148 ity of human albumin solutions compared with crystalloids in improving major outcomes, short-term adm
149 RTICIPANTS: The Precision Resuscitation With Crystalloids in Sepsis (PRECISE) trial is a parallel-gro
151 orrhagic shock may receive several liters of crystalloid, in addition to colloid solutions, in an att
155 6 and resulted in a decrease in mean 24-hour crystalloid infusion volume (6.1-3.2 L) and increased fr
158 three hundred thirty-six patients (48%) had crystalloid initiated in 30 minutes or lesser versus 2,3
163 ntensive care unit volume, and initial 24-hr crystalloid intensive care unit volume were all lower in
164 ume during the first 48 hrs post burn, total crystalloid intensive care unit volume, and initial 24-h
165 n saline (0.9% sodium chloride) and balanced crystalloids (lactated Ringer's solution or Plasma-Lyte
166 o Obviate Lung Injury]) and sepsis (CLOVERS [Crystalloid Liberal or Vasopressors Early Resuscitation
167 cohort study is a secondary analysis of the Crystalloid Liberal vs Early Vasopressors in Sepsis (CLO
168 nated PSVs from Brassica napus and defined a crystalloid-like fraction that contained integral membra
169 d-volume colloid (LV-Co), and limited-volume crystalloid (LV-Cr) resuscitation on the gut microbiota,
171 ) and lower mortality with albumin than with crystalloids (moderate confidence) or starches (moderate
172 ovolemia to achieve a minimum of 30 mL/kg of crystalloids (more rapid administration and greater amou
174 yethyl starches, or 4% or 20% of albumin) or crystalloids (n = 1443; isotonic or hypertonic saline or
175 ts assigned to saline (n = 454) and balanced crystalloids (n = 520) were similar at baseline and rece
177 ed in macrogametocytes, gets targeted to the crystalloids of developing ookinetes and is involved in
185 chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid c
186 uence of volume resuscitation with different crystalloid or colloid solutions on liver and intestine
188 nts with sepsis, resuscitation with balanced crystalloids or albumin compared with other fluids seems
189 hock associated with hypovolemia, the use of crystalloids or albumin to deliver a bolus of 20 mL/kg o
191 However, whether balanced or unbalanced crystalloids or natural or synthetic colloids confer a s
192 or albumin to deliver a bolus of 20 mL/kg of crystalloids (or albumin equivalent) over 5 to 10 mins (
193 lloid), hypervolemic (15 mL/kg/hour isotonic crystalloid), or hypertonic (3 mL/kg/hour isotonic cryst
194 dentify a parasite protein involved with the crystalloid organelle, and suggest a novel protein-traff
196 indicated that AQP1 plays a critical role in crystalloid osmosis, with clinically relevant effects on
197 rovessels, leading to a rapid decline of the crystalloid osmotic gradient, thereby decreasing aquapor
199 some monocotyledonous plants, but additional crystalloid P-proteins, known as forisomes, have evolved
200 patients received more fluid (4.0 vs. 2.5 L crystalloid, p < .001), earlier antibiotics (90 vs. 120
203 In additional experiments, using blood- and crystalloid-perfused hearts, we describe the relationshi
205 e have developed a simplified system of cold crystalloid perfusion and compared it with standard cold
207 l starch and gelatin periods compared to the crystalloid period (odds ratio, 1.46 [1.08, 1.97]; p = 0
209 mponents of forisomes, which are specialized crystalloid phloem proteins found solely in the Fabaceae
210 ts were randomized to receive either PGE1 or crystalloid placebo intravenously after allograft revasc
211 tes of intermittent 4 degrees C hyperkalemic crystalloid (Plegisol) or BCP with (+) or without (-) 5
218 g room have demonstrated that using balanced crystalloids rather than saline prevents the development
220 ing high chloride crystalloids, and balanced crystalloids represented 43%, 27%, and 16% of total volu
221 of the crystalloid, the correct targeting of crystalloid-resident protein LAP2, and malaria parasite
222 ly ill adults have examined whether balanced crystalloids result in less death or severe renal dysfun
224 of the 40-year-old standard of large volume crystalloid resuscitation for traumatic shock, greatly r
225 ults with severe falciparum malaria received crystalloid resuscitation guided by transpulmonary therm
226 Recognition of the limitations of standard crystalloid resuscitation has led to exploration for alt
227 e significant public health implications, as crystalloid resuscitation is nearly universal in sepsis.
228 The majority recovered well with standard crystalloid resuscitation or following a single colloid
229 is study were to 1) assess patterns of early crystalloid resuscitation provided to sepsis and septic
230 control and preload driven excessive use of crystalloid resuscitation were identified as modifiable
231 mine the association between time to initial crystalloid resuscitation with hospital mortality, mecha
232 blood was returned, i.e., immediately before crystalloid resuscitation, and were killed at 2 hrs afte
234 ve shown that resuscitation with colloid and crystalloid show no difference in outcomes in critically
235 e administration of only a minimal volume of crystalloid solution (2.8 mL/kg) and the absence of bloo
236 0.9% saline (30,994 patients) or a balanced crystalloid solution (926 patients) on the day of surger
241 ed method for infusion of O2, dissolved in a crystalloid solution at extremely high concentrations, i
242 reserved by perfusion with a cold oxygenated crystalloid solution for 4 h, transferred to a blood per
243 depend on its environment and (2) ONOO(-) in crystalloid solution impairs postcardioplegia systolic a
244 ts (ICUs), to receive either 20% albumin and crystalloid solution or crystalloid solution alone.
246 LP induced septic rats, whereas the balanced crystalloid solution showed stabilization of macro- and
247 is a physiologic, balanced multielectrolyte crystalloid solution that approximates the electrolyte c
248 ersus Plasma-Lyte A, a calcium-free balanced crystalloid solution, hypothesizing that Plasma-Lyte A w
251 o determine whether the volumes of blood and crystalloid solutions administered in the early posttrau
254 ume-dependent and linear fashion, the non-RL crystalloid solutions decreased the lactate concentratio
255 porting the choice of intravenous colloid vs crystalloid solutions for management of hypovolemic shoc
257 on of therapeutic components, beginning with crystalloid solutions infused to replace lost intravascu
258 Rationale: Administration of intravenous crystalloid solutions is a fundamental therapy for sepsi
259 ens are drawn from indwelling catheters, all crystalloid solutions must be cleared from the line.
262 albumin, starches, 0.9% saline, and balanced crystalloid solutions) administered and the different mo
263 0.01, 0.05, 0.10, 0.50, or 1.0 mL of various crystalloid solutions, containing or not containing RL,
264 deleterious effects of nitric oxide (NO) in crystalloid solutions, possibly due to a lack of detoxif
265 st the hypothesis that even small amounts of crystalloid solutions, which are inadequately "cleared"
269 otein was targeted to peroxisomes and formed crystalloid structures or cores similar to those present
271 Elamipretide-treated animals required less crystalloids than the controls (62.5 [50-90] and 25 [5-3
272 ht starch (low confidence) and with balanced crystalloids than with saline (low confidence) and low-
273 rotein is essential for the formation of the crystalloid, the correct targeting of crystalloid-reside
274 s article we review recent studies involving crystalloids, the 'new colloids', and on the amount and
275 o continue to require substantial amounts of crystalloid to maintain adequate mean arterial pressure
276 resuscitated with shed autologous blood and crystalloid to reach baseline cardiac output (0.9%), and
278 n the crystalloid group (fluid ratios 1.4:1 [crystalloids to hydroxyethyl starch] and 1.1:1 [crystall
280 After 1 hr, shed blood plus supplemental crystalloid (twice the shed blood volume) plus either ac
282 s 4% blood cardioplegia) and late death (24% crystalloid versus 21% blood cardioplegia) statistics we
285 bjectives: To compare the effect of balanced crystalloids versus saline on 30-day in-hospital mortali
286 There has been a shift toward a reduced crystalloid volume and the recreation of whole blood fro
290 ally similar except that men required higher crystalloid volumes, more often had a history of alcohol
293 cold (4 degrees C) antegrade BCP (8:1 blood:crystalloid) was delivered every 20 minutes for the firs
295 ated above-average doses of vasopressors and crystalloids were associated with improved outcomes when
297 l adults have associated receipt of balanced crystalloids with lower rates of complications, includin
299 (hazard ratio, 0.53-0.75; p < 0.001), 1-2 L crystalloids within the first 6 hours (hazard ratio 0.67